Ma, Q., Vaida, F., Wong, J., Sanders, C.A., Kao, Y.T., Croteau, D., Clifford, D.B., Collier, A.C., Gelman, B.B., Marra, C.M., McArthur, J.C., Morgello, S., Simpson, D.M., Heaton, R.K., Grant, I., Letendre, S.L., CHARTER Group (2016) Long-Term Efavirenz Use is Associated with Worse Neurocognitive Functioning in HIV-Infected Patients. Journal of NeuroVirology, 22, 170-178.
https://doi.org/10.1007/s13365-015-0382-7

has been cited by the following article:

• TITLE: Recent Advances in HIV-Associated Neurocognitive Disorders

  AUTHORS: Qianqian Tang, Hao Wu, Maogong Tang

  KEYWORDS: HIV-Associated Neurocognitive Disorders (HAND), Pathogenesis, Clinical Diagnosis and Treatment, Neuroimaging, Neuropsychological Assessment

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.9, September 18, 2023

  ABSTRACT: HIV-associated neurocognitive disorders (HAND) are chronic complications of HIV infection in the central nervous system. Clinical presentations include asymptomatic neurocognitive impairment (ANI), mild neurocognitive impairment (MND), and HIV-associated dementia (HAD). In the era of combination antiretroviral therapy (cART), the prevalence of HAD has significantly decreased, but the rates of ANI and MND have increased, impairing patients’ daily functioning, medical adherence, employment, driving abilities, risk of HIV transmission, overall quality of life, and posing challenges to society, economy, families, and public health. This article reviews the latest research findings regarding the pathogenesis, clinical diagnosis and treatment, neuroimaging, and neuropsychological assessment of HAND, aiming to provide insights into the prevention and management of HAND.